Search Result for : Cdsco

The Dollar Business Bureau In a bid to facilitate exports and make easier to do business, the Government on Wednesday eased the guidelines for drugs, medical devices and cosmetics exporters. Now the pharmaceutical companies will no longer have to get ‘no-objection’ certificate (NOC) from regulatory authority to export drugs and medical devices. “The pharmaceutical exporters can continue exporting without having to obtain no-objection certificates (NOC) from the regulatory authorities,” said the Central Drugs Standard Control Organisation (CDSCO) in a notice. Earlier, this facility was only available for exports to Australia, US, Japan, Canada, and European Union. Now CDSCO has extended the rule for exports to all other countries. “In partial modification of notice of even number dated December 11, 2015, removing the requirement of NOC for ...

The Dollar Business Bureau Lupin Ltd. on Monday announced it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to introduce Acotiamide 100 mg indigestion tablets in India. The introduction of the Acotiamide drug into the Indian pharmaceutical market is likely to benefit millions of patients suffering from Indigestion or Dyspepsia. Acotiamide strengthens gastric emptying and gastric accommodation: the factors implicated for functional dyspepsia. "Acotiamide is a first-in-class novel drug to be introduced into the Indian pharmaceutical market which could benefit millions of patients suffering from dyspepsia or indigestion, amongst the most common stomach complaints encountered in clinical practice," Lupin said in a statement. “We have a rich legacy of having introduced novel treatments to address unmet medical needs in the country. I am sure ...

The Dollar Business Bureau The bio-services sector which is currently valued at US$ 5-6 billion is set to increase to US$ 50 billion soon and we should be prepared to meet this growth. V K Subburaj, Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Fertilisers, made the above statement at a round-table meeting on ‘Unleashing Opportunities in Bio-Services Including Contract Research & Manufacturing’, in New Delhi, on Friday. Stating that India makes pharmaceutical products worth US$ 30 billion every year and is a leading producer of generics, the Secretary expressed hope that the bio-pharmaceuticals will take over the sector in future. Speaking at the meet, the Secretary further stated that the conducive atmosphere for growth has been missing in ...

Sai Nikesh | The Dollar Business  In a move to boost pharmaceutical industry, the Government of India is working towards the promotion of exports, especially by the micro and small enterprises of the pharma sector. This was informed by the Union Commerce Minister, Nirmala Sitharaman on Wednesday. The Union Minister informed that the Central Drugs Standard Control Organization (CDSCO) was unaware of the fact that majority of small pharma manufacturers are working for bigger pharmaceutical units which export the same under their brand name. In this regard, the government has taken various measures to promote exports by small and medium pharmaceutical manufacturers, which includes financial assistance through Pharmaceuticals Export Promotion Council of India (Pharmexcil), she added. Under the Market Development Assistance ...